Free MIMS Learning webinar: explaining genomic profiling results in breast cancer

On Monday 4 July 2022, at 7pm, consultant medical oncologist Dr Jay Naik will present a live webinar for oncologists and clinicians with an interest in genomic testing in breast cancer.

A head shot of a smiling, bespectacled Dr Jay Naik.

Breast cancer is one of the most common types of cancer in the UK, and it is the leading cause of death for cancer in the female population. Currently, there are four multigene tests that can guide adjuvant therapy for early breast cancer.

In this webinar for GPs, hospital doctors, oncologists, nurses, GP trainees and oncology trainees, consultant medical oncologist Dr Jay Naik will discuss how to read and interpret the results of these multigene tests, and how to use the results to identify the patients who would benefit from chemotherapy.

Why attend?

This free, live webinar offers you the chance to update your knowledge on the various genomic tests available for patients with breast cancer, determine patient suitability for each test, and interpret the results of commonly used genomic testing tools that will inform cancer treatment. The takeaways you gain from this webinar will add to what you already know about this rapidly expanding, evolving field.

At the end of the webinar, there will be a live Q&A session with Dr Naik.

Registration for this webinar is free and can be done on the MIMS Learning website. Simply click 'Start module' to enrol, and you’ll receive email reminders about the webinar.

If you have a question you’d like to submit in advance, please email

Want news like this straight to your inbox?
Sign up for our bulletins

Have you registered with us yet?

Register now to enjoy more articles and free email bulletins

Already registered?
Sign in

More from MIMS

Deleted products - live tracker

EXCLUSIVE TO SUBSCRIBERS See the latest products removed...

Products coming soon - live tracker

EXCLUSIVE TO SUBSCRIBERS Monitor forthcoming UK drug...

New products - live tracker

EXCLUSIVE TO SUBSCRIBERS See the latest products added...

Close-up image of a COVID-19 antibody

Suspending methotrexate therapy shown to improve COVID booster response

Findings from a recent study showed that a two-week...